In a study conducted in Israel, it was found that the third dose of the new coronavirus vaccine (COVID-19) produces 10 times more antibodies compared to the second dose.
The Israeli public broadcaster (KAN) published the results of the Sheba hospital research on the level of antibodies after the second and third dose of vaccination.
As part of the research, hospital health workers compared the level of antibodies after the second and third vaccinations.
As a result of the comparison it was observed that the level of antibodies of the third dose is 10 times higher compared to the second dose.
The number of people who have received the third dose reaches about 3 million
The Government of Israel, which has previously decided to gradually develop the third dose of the vaccine for different age groups, recently on August 29 it added to this group people over 12 years old.
In Israel, which has a population of about 9.4 million, the first dose of COVID-19 vaccine was given to 6 million 54 thousand citizens, 5 million 563 thousand to the second dose and 2 million 966 thousand to the third dose. .//AA
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.